Table of Contents Table of Contents
Previous Page  114 / 244 Next Page
Information
Show Menu
Previous Page 114 / 244 Next Page
Page Background

BRIDGE-ENHANCED ACL REPAIR: PRECLINICAL STUDIES

113

frequently observed after ACL injury and

reconstruction in human patients. However, the

underlying mechanism of the cartilage

protection is still not understood. The question

how collagen-platelet composites affect intra-

articular tissues is unknown but a subject of

ongoing investigation.

A collagen-platelet composite suffices as a

provisional scaffold and allows healing of an

immediately repaired ACL in the porcine

model. However, this technique was less

effective in the case of a repair performed with

a delay of two or six weeks. The reason might

be apoptosis, inflammation, or a matrix

degradation within the ACL after an injury.

To understand the reaction of the ACL to an

injury, different biological principles have been

described, as well as the intra-articular milieu,

where healing would occur. Within the

ligament, fibroblasts undergo nitric oxide-

induced and caspase 9-mediated apoptosis

early after injury. Moreover, protein fragments

increase, indicating a type I collagen breakdown

[9]. These findings suggest a degradative

environment, modulated by highly activated

matrix metalloproteinases which break down

collagen proteins. The synovial membrane, as

well as the injured ligament itself after an

injury, produces these enzymes [2, 9].

Addressing the synovial fluid milieu could

enhance the understanding or possible

counteractions of these processes and improve

the results of ACL repair [5].

To decrease the cartilage breakdown in the knee

by injecting therapeutic agents could be a

potential strategy to slow or prevent the

development of post-traumatic osteoarthritis

after an ACL injury. A scenario may include

caspase inhibition to decrease fibroblast apop­

tosis or to apply antagonists of inflammatory

cytokines (e.g., interleukin1 receptor antagonist).

Also, reducing the activity of metalloproteinase

might help. Therefore, short-term intra-articular

treatment with these therapeutic agents might

influence the detrimental biological processes

that initiate ligament and cartilage degradation

after ACL injury [5, 6].

Fig. 1:

Bridge-enhanced ACL repair. (

a

) Transected ACL. (

b

) Femoral and tibial tunnels (dashed lines) and

EndoButton (Smith & Nephew Endoscopy, Andover, MA) pulled through femoral tunnel and placed on

femoral cortex. The EndoButton is loaded with 3 sutures, resulting in 6 free-ending strands (4 red and

2 green). (

c

) A Kessler suture is placed in the tibial ACL stump, and a collagen scaffold is threaded onto

4 strands (red), pushed into the notch, and saturated with 3mL of autologous blood. (

d

) The 4 suture

strands running through the scaffold (red) are passed through the tibial tunnel, whereas the remaining

suture (green) is tied to the tibial Kessler suture, using it as a pulley to reduce and stabilize the tibial ACL

stump. (

e

) The transtibial sutures (red) are tightened and tied over an extracortical button. The free ends

of the ACL suture pulley (green) are knotted to secure the reduced ACL in the collagen-platelet composite.

Reprinted with permission [10].

a

b

c

d

e